Tag: addiction

May 22, 2018

5 Top Weekly NASDAQ Biotech Stocks: Vivus on Top

Eiger BioPharmaceuticals, ArQule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences, were last week's top gainers on the NASDAQ.
May 20, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 3, 2018

Australia: A Burgeoning Medicinal Cannabis Market

Australia has signaled its acceptance of cannabis’ legitimate medical applications, and growth opportunities are rising for newly licensed producers.
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 29, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 27, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 26, 2018

Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical Cannabis

Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that it continues...
April 26, 2018

Kalytera Issues CEO Letter to Shareholders

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today issued the following letter to shareholders from the Company’s President...
April 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Novelion on Top

Novelion Therapeutics, EyePoint Pharmaceuticals, CytRx, Viking Therapeutics and AVEO Pharmaceuticals were last week's top gainers.